Candrilli SD, Kuznik A, Rudolph AE. The prevalence and overlap of select cardiovascular comorbidities among US adults with dyslipidemia, by lipid-lowering medication use. Poster presented at the Annual Meeting of the American College of Clinical Pharmacy; October 2007.
Candrilli SD, Kuznik A, Rudolph AE. The prevalence and overlap of select cardiovascular comorbidities among the US elderly with dyslipidemia, by lipid-lowering medication use. Poster presented at the Annual Meeting of the American College of Clinical Pharmacy; October 2007.
Johannes CB, Seeger JD, Koro CE, Cutone JA, Quinn SG. Response to a comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'. Pharmacoepidemiol Drug Saf. 2007 Oct 1;16(10):1073-4.
Menzin J, Wygant G, Hauch O, Friedman M, Jackel J. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Poster presented at the Educational Conference of the Academy of Managed Care Pharmacy; October 2007.
Mines D, Fireman B, Lee J, Go AS. Venlafaxine use was not associated with an increased risk of sudden cardiac death. Presented at the 23rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2007. Quebec City, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2007 Aug; 16(Suppl 2):S7.
Varas-Lorenzo C, Rodriguez LA, Maguire A, Castellsague J, Perez-Gutthann S. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis. 2007 Jun;192(2):376-83.
Pladevall-Vila M, Williams LK, Elston Lafata J, Wang M, Campbell J, Yang J, Divine G. Adherence to lipid lowering drugs is associated with ldl-cholesterol goal achievement. Poster presented at the Society for Epidemiological Research; June 2007. [abstract] Am J Epidemiol. 165(Suppl_11):S-11.
Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Pleil A, Zlateva G. Balancing visual acuity benefits with systemic adverse effects in anti-VEGF therapy. Poster presented at the ARVO 9th Annual Meeting; May 2007; May 2007. Fort Lauderdale, FL.
Earnshaw SR, Wilson MR, Joshi AV. Cost-effectiveness of recombinant activated factor vii in the treatment of intracerebral hemorrhage over a two-year managed care enrollment period. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(2):A182. Previously presented at the 2006 International Stroke Conference.
Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger JD. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy. Pharmacoepidemiol Drug Saf. 2007 May 1;16(5):504-12.
Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Pharmacoepidemiol Drug Saf. 2007 Apr 1;16(4):366-76.
Candrilli SD, Lee E, Tang SSK, Bassin S, Laird HJ, Levy SS, Wong ND. Cardiovascular risk in US urban hispanic populations: regional data from community outreach programs. Poster presented at the American College of Cardiology 56th Annual Scientific Session; March 27, 2007.
Tang SSK, Lee E, Candrilli SD, Laird HJ, Levy SS, Bassin S, Wong ND. Prevalence, treatment, and control of hypertension and/or dyslipidemia among hispanic adults in US communities. Poster presented at the American College of Cardiology 56th Annual Scientific Session; March 27, 2007.
Lee E, Tang SSK, Candrilli SD, Bassin S, Laird HJ, Levy SS, Wong ND. Regional differences in the prevalence of hypertension and dyslipidemia in US urban hispanic populations. Poster presented at the American College of Cardiology 56th Annual Scientific Session; March 27, 2007.
Pignone M, Earnshaw S, Pletcher MJ, Tice JA. Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Arch Intern Med. 2007 Feb 12;167(3):290-5.
Umscheid CA, Maguire MG, Pines JM, Everett WW, Baren JM, Townsend RR, Mines D, Szyld D, Gross R. The prevalence of and risk factors associated with untreated hypertension in ED patients. Poster presented at the 2007 Society for Academic Emergency Medicine Conference; May 2007. Chicago, IL. [abstract] Acad Emerg Med. 2007; 14(5 Suppl 1):S117.
Earnshaw SR, Wilson M, Joshi AV. The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgets. Managed Care Interface. 2007 Jan 1;19(11):39-45.
Payne JR, James LE, Eleftheriou KI, Hawe E, Mann J, Stronge A, Banham K, World M, Humphries SE, Pennell DJ, Montgomery HE. The association of left ventricular mass with blood pressure, cigarette smoking and alcohol consumption; data from the LARGE Heart study. Int J Cardiol. 2007;120(1):52-8.
Rothman KJ, Fyler DC. Seasonal occurrence of complex ventricular septal defect. Lancet. 1974 Jul 27;304(7874):193-7. doi: 10.1016/S0140-6736(74)91486-X